SG10201700267PA - Prophylactic or therapeutic drug for constipation - Google Patents
Prophylactic or therapeutic drug for constipationInfo
- Publication number
- SG10201700267PA SG10201700267PA SG10201700267PA SG10201700267PA SG10201700267PA SG 10201700267P A SG10201700267P A SG 10201700267PA SG 10201700267P A SG10201700267P A SG 10201700267PA SG 10201700267P A SG10201700267P A SG 10201700267PA SG 10201700267P A SG10201700267P A SG 10201700267PA
- Authority
- SG
- Singapore
- Prior art keywords
- constipation
- prophylactic
- therapeutic drug
- therapeutic
- drug
- Prior art date
Links
- 206010010774 Constipation Diseases 0.000 title 1
- 229940043274 prophylactic drug Drugs 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 229940126585 therapeutic drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013019754 | 2013-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201700267PA true SG10201700267PA (en) | 2017-02-27 |
Family
ID=51262485
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201506047PA SG11201506047PA (en) | 2013-02-04 | 2014-02-03 | Prophylactic or therapeutic drug for constipation |
| SG10201700267PA SG10201700267PA (en) | 2013-02-04 | 2014-02-03 | Prophylactic or therapeutic drug for constipation |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201506047PA SG11201506047PA (en) | 2013-02-04 | 2014-02-03 | Prophylactic or therapeutic drug for constipation |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10022389B2 (he) |
| EP (1) | EP2952206B1 (he) |
| JP (1) | JP5807767B2 (he) |
| KR (1) | KR102078433B1 (he) |
| CN (1) | CN104955481B (he) |
| AU (1) | AU2014213251B2 (he) |
| BR (1) | BR112015017541A2 (he) |
| CA (1) | CA2899834C (he) |
| ES (1) | ES2694110T3 (he) |
| HK (1) | HK1211479A1 (he) |
| IL (1) | IL240192A (he) |
| MX (1) | MX346453B (he) |
| MY (1) | MY176162A (he) |
| PH (1) | PH12015501696B1 (he) |
| RU (1) | RU2648467C2 (he) |
| SG (2) | SG11201506047PA (he) |
| TW (1) | TWI659739B (he) |
| WO (1) | WO2014119787A1 (he) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019142774A (ja) * | 2016-06-20 | 2019-08-29 | 大正製薬株式会社 | 腸内環境改善剤 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2830424C3 (de) * | 1978-07-11 | 1982-04-15 | Bayer Ag, 5090 Leverkusen | alpha -Glucosidase-Inhibitoren |
| US5651988A (en) | 1995-08-18 | 1997-07-29 | Xyrofin Oy | Combination osmotic and bulk forming laxatives |
| EP1544208B1 (en) | 2002-08-08 | 2010-05-26 | Kissei Pharmaceutical Co., Ltd. | Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| JP2004137245A (ja) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
| AU2003262262A1 (en) | 2002-08-27 | 2004-03-19 | Kissei Pharmaceutical Co., Ltd. | Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof |
| JPWO2004050122A1 (ja) | 2002-12-04 | 2006-03-30 | キッセイ薬品工業株式会社 | 高血糖症に起因する疾患の予防又は治療剤 |
| DE102004028241B4 (de) | 2004-06-11 | 2007-09-13 | Sanofi-Aventis Deutschland Gmbh | Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel |
| TWI387454B (zh) * | 2004-09-02 | 2013-03-01 | Sucampo Ag | 治療胃腸道疾病之方法及組成物 |
| MX2008014512A (es) | 2006-05-19 | 2008-11-27 | Taisho Pharma Co Ltd | Compuesto de c-fenil glucitol para el tratamiento de diabetes. |
| JP5152519B2 (ja) | 2006-06-29 | 2013-02-27 | 大正製薬株式会社 | Ｃ−フェニル１−チオグルシト−ル化合物 |
| TW200817424A (en) | 2006-08-04 | 2008-04-16 | Daiichi Sankyo Co Ltd | Benzylphenyl glucopyranoside derivatives |
| TWI499414B (zh) | 2006-09-29 | 2015-09-11 | Lexicon Pharmaceuticals Inc | 鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法 |
| AU2007332476A1 (en) | 2006-12-14 | 2008-06-19 | Taisho Pharmaceutical Co., Ltd. | 1-phenyl 1-thio-D-glucitol derivative |
| GB2447067A (en) * | 2007-02-20 | 2008-09-03 | Branko R Babic | Alteration of osmotic gradients by polyhydroxy compounds |
| CN101910189B (zh) | 2007-12-27 | 2013-06-19 | 橘生药品工业株式会社 | 吡唑衍生物的单癸二酸盐 |
| ES2385185T3 (es) | 2008-04-16 | 2012-07-19 | Kissei Pharmaceutical Co., Ltd. | Hemifumarato de un derivado de pirazol |
| WO2010095768A1 (en) * | 2009-02-23 | 2010-08-26 | Taisho Pharmaceutical Co., Ltd. | 4 -isopropylphenyl glucitol compounds as sgltl inhibitors |
| JP2013224263A (ja) | 2010-08-19 | 2013-10-31 | Taisho Pharmaceutical Co Ltd | ４−イソプロピルフェニルグルシトール化合物 |
| CA2807755A1 (en) | 2010-08-20 | 2012-02-23 | Taisho Pharmaceutical Co., Ltd. | Crystal form of 4-isopropylphenyl glucitol compound and process for production thereof |
| EP2607360B1 (en) | 2010-08-20 | 2015-08-19 | Taisho Pharmaceutical Co., Ltd. | 4-Isopropyl-6-methoxyphenyl glucitol compound |
| AR087701A1 (es) | 2011-08-31 | 2014-04-09 | Japan Tobacco Inc | Derivados de pirazol con actividad inhibidora de sglt1 |
| BR112014027841B1 (pt) | 2012-05-07 | 2022-08-09 | Kissei Pharmaceutical Co., Ltd | Uso de derivados de pirazola na fabricação de um fármaco para prevenir ou tratar constipação |
| KR102165224B1 (ko) | 2012-11-20 | 2020-10-13 | 렉시컨 파마슈티컬스 인코퍼레이티드 | 나트륨 글루코스 공동수송체 1의 억제제 |
-
2014
- 2014-02-03 MX MX2015010029A patent/MX346453B/es active IP Right Grant
- 2014-02-03 RU RU2015137671A patent/RU2648467C2/ru active
- 2014-02-03 AU AU2014213251A patent/AU2014213251B2/en not_active Ceased
- 2014-02-03 SG SG11201506047PA patent/SG11201506047PA/en unknown
- 2014-02-03 EP EP14746685.8A patent/EP2952206B1/en active Active
- 2014-02-03 JP JP2014526017A patent/JP5807767B2/ja not_active Expired - Fee Related
- 2014-02-03 MY MYPI2015702526A patent/MY176162A/en unknown
- 2014-02-03 ES ES14746685.8T patent/ES2694110T3/es active Active
- 2014-02-03 CN CN201480007190.8A patent/CN104955481B/zh not_active Expired - Fee Related
- 2014-02-03 KR KR1020157018999A patent/KR102078433B1/ko active IP Right Grant
- 2014-02-03 SG SG10201700267PA patent/SG10201700267PA/en unknown
- 2014-02-03 CA CA2899834A patent/CA2899834C/en active Active
- 2014-02-03 BR BR112015017541A patent/BR112015017541A2/pt not_active Application Discontinuation
- 2014-02-03 WO PCT/JP2014/052465 patent/WO2014119787A1/ja active Application Filing
- 2014-02-03 US US14/765,134 patent/US10022389B2/en active Active
- 2014-02-05 TW TW103103751A patent/TWI659739B/zh not_active IP Right Cessation
-
2015
- 2015-07-28 IL IL240192A patent/IL240192A/he active IP Right Grant
- 2015-07-31 PH PH12015501696A patent/PH12015501696B1/en unknown
- 2015-12-15 HK HK15112295.0A patent/HK1211479A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI659739B (zh) | 2019-05-21 |
| EP2952206B1 (en) | 2018-10-24 |
| JP5807767B2 (ja) | 2015-11-10 |
| WO2014119787A1 (ja) | 2014-08-07 |
| CA2899834A1 (en) | 2014-08-07 |
| CA2899834C (en) | 2020-09-01 |
| PH12015501696A1 (en) | 2015-10-12 |
| BR112015017541A2 (pt) | 2017-07-11 |
| MX2015010029A (es) | 2015-10-30 |
| ES2694110T3 (es) | 2018-12-18 |
| PH12015501696B1 (en) | 2015-10-12 |
| EP2952206A4 (en) | 2016-06-15 |
| IL240192A0 (he) | 2015-09-24 |
| KR102078433B1 (ko) | 2020-02-17 |
| RU2015137671A (ru) | 2017-03-10 |
| MX346453B (es) | 2017-03-17 |
| CN104955481A (zh) | 2015-09-30 |
| KR20150112949A (ko) | 2015-10-07 |
| HK1211479A1 (en) | 2016-05-27 |
| CN104955481B (zh) | 2017-10-24 |
| JPWO2014119787A1 (ja) | 2017-01-26 |
| RU2648467C2 (ru) | 2018-03-26 |
| US20150374735A1 (en) | 2015-12-31 |
| AU2014213251B2 (en) | 2017-07-20 |
| MY176162A (en) | 2020-07-24 |
| SG11201506047PA (en) | 2015-09-29 |
| US10022389B2 (en) | 2018-07-17 |
| EP2952206A1 (en) | 2015-12-09 |
| AU2014213251A1 (en) | 2015-08-27 |
| TW201517903A (zh) | 2015-05-16 |
| IL240192A (he) | 2017-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20180684T1 (hr) | Kombinacija lijekova | |
| ZA201507576B (en) | Pharmaceutical combination drug | |
| GB201308440D0 (en) | Therapeutic | |
| HK1223833A1 (zh) | 藥物劑型 | |
| ZA201600027B (en) | Pharmaceutical preparation | |
| EP3046556A4 (en) | Combination drug therapy | |
| EP2968179A4 (en) | RETARD-PRESENTATIONS | |
| GB201318668D0 (en) | Sonosensitive therapeutic | |
| HK1220633A1 (zh) | 含有氨基吡唑衍生物的藥物製劑 | |
| HK1211479A1 (en) | Prophylactic or therapeutic drug for constipation | |
| ZA201506465B (en) | Pharmaceutical preparation | |
| GB201320786D0 (en) | Medicament | |
| GB201316662D0 (en) | Pharmaceutical Combination | |
| GB201305073D0 (en) | Therapeutic means |